How can we make food healthier, more sustainable, and packed with essential nutrients—all without relying on traditional agriculture? In this episode, we sit down with Frank Jaksch, founder of Ayana Bio, to explore the cutting-edge world of plant cell culture technology and how it’s revolutionizing the way we think about nutrition. From his early days in chemistry and drug discovery to launching Ayana Bio, Frank shares his insights on the growing concerns around ultra-processed foods, the declining nutrient density in fresh produce, and how his company is developing bioactive compounds that can fortify everyday products—without sacrificing taste, cost, or sustainability. We also discuss the broader food security and climate challenges, the need for industry-wide collaboration, and how Ayana Bio is working with brands to create smarter, nutrient-dense alternatives to conventional food products. Plus, get an exclusive look into the upcoming Future Food Tech event, where innovative startups and ingredient pioneers will come together to shape the next chapter of food innovation.
Episode Breakdown:
🕒 00:00 – Introduction and Guest Welcome
🧪 00:24 – Frank’s Background and Career Journey
🍔 03:53 – The Rise of Ultra-Processed Foods
📉 05:30 – Health Impacts and Consumer Awareness
🥦 06:47 – Challenges with Fresh Food and Nutrient Density
🌱 14:11 – Ayana Bio’s Innovative Approach
🌍 19:45 – The Future of Food and Sustainability
💡 25:27 – Practical Solutions and Industry Collaboration
🔚 34:23 – Conclusion and Final Thoughts
Tune in to this fascinating discussion at the intersection of science, food tech, and sustainability, and discover how innovation is shaping the future of what we eat., and check out his upcoming panel at Future FoodTech in San Francisco🚀
About Frank Jaksch: Frank Jaksch serves as Ayana Bio’s Chief Executive Officer and is a member of its Board of Directors. As founder and former CEO of ChromaDex (NASDAQ: CDXC), Frank has more than 25 years’ experience developing plant bioactives and natural ingredient solutions in the life science, food, beverage, and dietary supplement spaces. He has built an ingredient and end consumer product business from the ground up, ultimately taking the company public on NASDAQ. Having been immersed in the world of natural products for decades, Frank understands the significant challenges encumbering the space. To date, sourcing health and wellness natural products from agriculture has proven unsustainable and unwieldy; and product quality has suffered from adulteration largely owing to supply scarcity and costly development expenses. At the helm of Ayana Bio, Frank seeks to modernize the health and wellness sector and in so doing provide affordable and reliable ingredients. He believes that Ayana Bio’s technology platform is key to developing a scientific solution to reliability and cost.
